Explores the history, mechanisms, and players of cancer immunotherapies, including immune evasion strategies and the role of MHC in antigen presentation.
Explores the activation and differentiation of T lymphocytes, focusing on naive T cells recognizing antigens and differentiating into effector and memory cells.
Introduces the emerging field of immunoengineering, covering interactions between engineering and immunology, genetically engineered immune cells for cancer therapy, and key technologies in immunological analysis.
